Related by context. All words. (Click for frequent words.) 81 ® bortezomib 75 R Bortezomib 74 ® decitabine 72 pralatrexate injection folate analogue 72 Crofelemer budesonide foam 72 Aloprim TM allopurinol sodium 71 Combination REOLYSIN R 71 palonosetron hydrochloride Injection Dacogen 71 FUSILEV ® 70 co promotes INTEGRILIN 70 Pruvel TM 70 XL# anticancer compounds 70 INTEGRILIN R eptifibatide Injection 70 MOVIPREP R 70 R sorafenib tablets 70 TRANSDUR ® 70 Staphylococcus aureus Immune Globulin 70 Submits NDA 70 ZEVALIN ® 69 oncolytic virus therapies 69 Onyx Pharmaceuticals Announces 69 AAG geldanamycin analog 69 Personalized Immunotherapy 69 ATRA IV 69 modified glutathione analog 69 pentadentate logo R 69 novel topoisomerase 69 Receives Orphan Drug 69 methylnaltrexone bromide 69 IMiDs R 69 COLAZAL R 69 Levoleucovorin 69 candidates Azedra TM 68 Solazed TM 68 Vitrasert R 68 Wafer polifeprosan 68 Receives Orphan Drug Designation 68 Aloxi R 68 DIFICID ™ 68 Clolar ® 68 R famotidine 68 VIVITROL ® 68 novel orally inhaled 68 Initiates Enrollment 68 refractory chronic lymphocytic 68 Archexin 68 include Alferon N 68 topical antifungal product 68 Zorbtive TM 68 Cardium Therapeutics TM 68 peptidic compound 68 personalized cellular immunotherapy 68 Meets Primary Endpoint 68 Completes Patient Enrollment 68 Hsp# Inhibitor 68 Begins Dosing 68 Tezampanel 68 VISICOL R 67 evaluating picoplatin 67 sapacitabine CYC# 67 please visit www.abraxane.com 67 oral proteasome inhibitor 67 Initiates Phase II 67 VELCADE novel 67 Patient Enrollment 67 Pirfenidone 67 Achieves Primary Endpoint 67 VYVANSE TM lisdexamfetamine 67 Intravenous Human 67 Xeloda ® 67 GVAX ® 67 R MSCRAMM 67 Xcytrin R 67 progressive metastatic prostate 67 * Azixa 67 SPRYCEL ® 67 IMiDs ® 67 candidate REP# 67 Telik logo TELINTRA 67 Receives Approvable Letter 67 telomerase therapeutic 67 markets COLAZAL 67 monoclonal antibody IgG1 Mab 67 TELINTRA R 67 molecular imaging radiopharmaceutical 67 Initiates Phase III 67 highly purified pasteurized 67 agonistic human 67 tumor activated prodrug 67 Granted Orphan Drug 67 Files IND 67 Phase 2a Trial 67 mitogen activated ERK kinase 67 antiangiogenesis therapies 67 IgG1 monoclonal antibody 67 ThermoDox R 67 Romidepsin 67 Peginterferon alfa 2b 67 R Saizen R 67 Phase 2b Clinical Trial 67 * olmesartan medoxomil 67 Empatic TM 67 TRANSDUR ™ 67 novel emulsion formulation 67 TRIOLEX HE# APOPTONE HE# 66 Budesonide foam crofelemer 66 FOLOTYN ® 66 MKC# MT 66 Besivance 66 Vaccine Adjuvant 66 Drug Candidate 66 HuCAL PLATINUM ® CysDisplay 66 Therapeutic Competitors Companies 66 Phase IIb Clinical Trial 66 Aflibercept VEGF Trap 66 individualized cellular immunotherapy 66 BCG refractory carcinoma 66 Psoriasis Drug 66 label Lipofen R 66 IMiDs ® compound 66 Telik Announces 66 Vidaza R 66 Nexavar ® 66 sorafenib tablets 66 Amigal TM 66 Panzem R 66 Adjuvant Treatment 66 motexafin gadolinium Injection 66 Amgen Neulasta R 66 Auxilium transmucosal film 66 Zemiva TM 66 Glufosfamide 66 forodesine purine nucleoside phosphorylase 66 R pegaptanib sodium 66 Numoisyn R 66 Submits Biologics License Application 66 dextromethorphan quinidine 66 delivers fluocinolone acetonide FA 66 TRACON Pharmaceuticals 66 Initiate Clinical Trial 66 TM Aganocide 66 vaccines oncolytic virus 66 triggers apoptosis programmed 66 Ovitrelle R Serostim 66 First Patient Enrolled 66 M# rationally 66 PEGylated docetaxel 66 Trial Evaluating 66 rash pruritus nausea 66 dihydrochloride Phase 3 66 mitoxantrone concentrate 66 product platforms AZX# 66 ELADUR ™ 66 markets Gelclair R 66 ® adefovir dipivoxil 66 rusalatide acetate 66 INTEGRILIN ® 66 MKC# MKC# PP 66 novel antimitotic agent 66 Pruvel ™ 66 IMPDH inhibitor 66 PEG PAL PEGylated recombinant 66 ferumoxytol Injection 66 R eptifibatide Injection 66 Medarex logo 66 First Patient Dosed 66 www.ucb group.com 66 Salix Pharmaceuticals Announces 66 Receives Milestone Payment 66 GlycoPEGylated hemostasis compounds 66 Receives Positive Opinion 66 novel synthetic PEGylated 65 drugs FUSILEV 65 Luveris R Ovidrel R 65 palonosetron hydrochloride injection 65 PRN FDA Approves 65 Provectus Pharmaceuticals specializes 65 acetylgalactosamine 6 65 novel VDA molecule 65 SPL# Gel vaginal microbicide 65 6 sulfatase 65 diagnostic molecular imaging 65 FDA Accepts 65 SinuNase ™ 65 oral picoplatin 65 Boxed Warnings 65 Lubiprostone 65 USP Tablets PEPCID 65 Nipent R 65 fibrosis IPF 65 LymphoStat B belimumab 65 Xolegel Vusion 65 targeted immunotherapies 65 CB2 selective receptor agonist 65 CysDisplay R 65 hypoxia activated prodrug 65 acyclovir Lauriad R 65 Tesetaxel 65 investigational pharmacologically unique 65 humanized therapeutic 65 accumulate preferentially 65 seliciclib CYC# 65 recurrent metastatic ovarian cancer 65 vinorelbine tartrate 65 Submits Supplemental 65 GATTEX TM 65 Initiates Clinical Trial 65 Unigene nasal calcitonin 65 Mylan Receives Approval 65 treat refractory angina 65 oral dual endothelin 65 ELADUR TM 65 Ceflatonin R 65 HepeX B TM 65 candidate deforolimus 65 METOZOLV ™ ODT metoclopramide 65 semi synthetic lipoglycopeptide 65 Solution XOPENEX HFA 65 CYP#A# isoenzyme 65 phenylalanine ammonia lyase 65 pan histone deacetylase 65 Demonstrates Significant 65 erlotinib Tarceva R 65 platform HDL Mimetic 65 Nventa proprietary CoVal 65 intravesical infusion therapy 65 Selzentry Celsentri 65 folate analogue metabolic 65 Evoltra ® 65 MEK Inhibitor 65 R bivalirudin 65 androgen receptor modulator 65 Peyronie disease Frozen Shoulder 65 Voreloxin 65 TKB# 65 HCl PEPCID ® famotidine 65 Edwards Lifesciences AG 65 investigational oral inhibitor 65 Phase #b/#a clinical 65 FOLFOX6 chemotherapy regimen 65 PNP inhibitor 65 Pivotal Phase III 65 polysaccharide polymer 65 Phase III Trial 65 mild vasodilator 65 PROSTASCINT R 65 Completes Enrollment 65 NU# direct 65 TAFA# 65 PROVENGE ® 65 interferon beta 1a infertility 65 dasatinib Sprycel ® 65 selective immunoproteasome inhibitor 65 Brentuximab Vedotin SGN 65 RECOTHROM ® 65 using VIAdel TM 65 substantially excreted 65 sodium sulfate sodium chloride 65 mocetinostat MGCD# 65 dermatology therapies 65 CYP#A# CYP#D# 65 induced macular edema 65 TO AVOID PREGNANCY WHILE 65 ocular formulation 65 candidates Azedra 65 allosteric modulator NAM 64 please visit http:/www.vandapharma.com 64 CYT# potent vascular disrupting 64 Campath ® 64 VEGFR2 inhibitor 64 Initiate Phase III 64 Oracea TM 64 Patients Treated With 64 Serostim ® 64 Zemiva TM Trofex TM 64 syndrome overactive bladder 64 formerly LymphoStat B 64 topical non steroidal 64 LEVADEX TM 64 overactive bladder AA# 64 subsidiaries visit http:/www.apricusbio.com 64 Gel repository corticotropin injection 64 Allos Therapeutics Announces 64 DepoCyt ® Abelcet ® 64 NEBIDO R 64 targeted radiotherapeutic 64 OTC BB PVCT 64 developing Bicifadine serotonin 64 brand ciclesonide HFA 64 targets Galectin receptors 64 KRYSTEXXA TM pegloticase 64 include PLX IBD 64 Immunotherapeutic 64 rHuPH# recombinant human 64 SABER ™ 64 promotes MERREM ® 64 DNA methyltransferase inhibitors 64 Cutaneous T 64 ANYARA 64 Vitrasert ® 64 inflammatory PDE 64 Tramiprosate ALZHEMED TM 64 Receives Fast Track 64 ONSOLIS TM 64 mesylate tablets approved 64 PDX pralatrexate 64 compound perifosine 64 Mersana Therapeutics Inc. 64 IMiDs 64 NS5B polymerase 64 Neulasta R 64 TURNING INSIGHTS INTO HOPE 64 Through Glycoscience 64 VANTAS ® 64 endoscopic autofluorescence imaging 64 Combivir Kivexa 64 elderly myelodysplastic syndromes 64 commercialize CorMedix drug 64 Elagolix 64 Darinaparsin 64 Surgical Adhesive 64 Generic Version 64 Announces Tentative Approval 64 oral beclomethasone dipropionate 64 Barr Receives Approval 64 Zalypsis 64 DOS# 64 Alfacell proprietary ribonuclease 64 PEGylated Fab fragment 64 addressing idiopathic pulmonary 64 Oral Solution OSMOPREP 64 Exelixis compounds 64 Quinamed R 64 targeting Inflammatory Bowel 64 Pegloticase 64 active AKT inhibitor 64 topical anti infective 64 mGluR5 negative 64 Restoraderm R 64 BioGlue ® 64 Empatic ™ 64 Isolagen specializes 64 events thrombocytopenia neutropenia 64 Azedra TM 64 Romiplostim 64 Study Evaluating 64 R lenalidomide 64 commercializing oxidized glutathione 64 oral prodrug 64 dependent kinase inhibitor 64 Phase 2a Clinical Trial 64 ® ZEVALIN 64 Aloxi ® 64 5 HT3 antagonist 64 systemic anaplastic large 64 Investigational Treatment 64 ERBITUX cetuximab 64 Adagen ® 64 coronary stent merged 64 sapropterin dihydrochloride Phase 64 MSCRAMM ® 64 secretory phospholipase A2 64 Vitamin D analogue 64 Completes Patient Enrolment 64 Abstract Accepted 64 nanofiltered plasma derived 64 include Phenoptin TM 64 product candidate Lpathomab 64 RANK Ligand inhibitor 64 FDA Okays 64 cosmetic cosmeceutical products 64 Retisert ® 64 migraine headaches neuropathic pain 64 Presents Preclinical Data 64 novel DACH platinum 64 Excellarate TM 64 Bazedoxifene 64 GVAX R 64 products MKC# PP 64 CDK cyclin dependent 64 Previously Treated 64 Zemiva ™ 64 FDA APPROVES 64 TNF Tumor Necrosis Factor 64 induced mucositis 64 ibuprofen Injection 64 Initiates Clinical 64 Teva Provides Update 64 5 FU leucovorin 64 R pramlintide acetate 64 4SC AG ISIN DE# 64 rheumatoid arthritis Roche PEGASYS 64 Veronate R 64 topical gel formulation 64 Replagal TM 64 INSPIRE Trial Phase III 64 evaluating tivozanib 64 AN# topical anti 64 include Altastaph TM 64 Alvine Pharmaceuticals 64 Locteron exclusively 64 doxercalciferol 64 DARA logo 64 Aeolus Pharmaceuticals Announces 64 virus HCV protease inhibitor 64 ARCALYST R 64 R bendamustine hydrochloride 64 Potassium Chloride Sodium Ascorbate 64 SYCREST 64 Phase IIb Trial 64 Through Glycoscience R 64 ® DS methenamine 64 class anticancer quinolone 64 particularly SANCTURA XR 64 Demonstrates Positive 64 R brand eszopiclone 64 carcinoma mCRC 64 NDA Submission 64 mesylate tablets fluoroquinolone antibiotic 64 sapropterin dihydrochloride 64 selective A2A adenosine receptor 63 novel histone deacetylase 63 manufactures minimally invasive 63 Serdaxin ® 63 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 63 product Fentanyl TAIFUN 63 ALN PCS 63 Antitumor Activity 63 REVLIMID R 63 GALNS N acetylgalactosamine 63 NOTE POSIDUR ™ 63 include Healive 63 PREOS R 63 HuMax TAC 63 Ltd. Teva Neuroscience 63 Vicriviroc 63 HYVISC ® treatment 63 include VALSTAR TM 63 products Oncaspar ® 63 Indibulin Zybulin TM 63 HER2 Positive Breast Cancer 63 Phase III Clinical Trial 63 KALBITOR ® 63 Dural Regeneration Matrix 63 Tibotec Therapeutics division 63 Presents Positive 63 AVASTIN 63 topically applied SEPA 63 ® lenalidomide 63 Pharma Merck Serono 63 Thalomid ® 63 UCB www.ucb group.com 63 commercialized DURECT 63 rasagiline tablets 63 Epeius Biotechnologies Corporation 63 Aztreonam Lysine 63 AzaSite TM 63 sores onychomycosis nail 63 anthracycline derivative 63 inflammation autoimmune diseases 63 Expanded Indication 63 investigational humanized monoclonal antibody 63 SinuNase TM 63 phenyl salicylate methylene blue 63 PATHFINDER ® TRACER 63 BiovaxID TM 63 evaluating satraplatin 63 infectious diseases autoimmune diseases 63 Aldurazyme ® 63 nasal calcitonin product 63 Clinical Trial Results 63 Fast Track Status 63 OctoPlus licensed 63 Frozen Shoulder syndrome Adhesive 63 R metformin Concor 63 Exherin 63 Rigel R# 63 Aflibercept 63 Taro Receives 63 metaglidasen 63 ® EBLY ® MASTERFOODS 63 lead molecular radiotherapeutic 63 Chloride Tl 63 PrevOnco ™ 63 Investigational Compound 63 http:/www.celgene.com 63 Omacetaxine 63 ankylosing spondylitis psoriatic arthritis 63 RECOTHROM R 63 human C1 inhibitor 63 YONDELIS 63 Inc. www.micromet inc.com 63 CCR9 antagonist 63 pharmacogenomic translational research 63 commercializing dermatological products 63 MKC# 63 R olmesartan medoxomil 63 Phase 1b Clinical Trial 63 www.syntapharma.com 63 Therapeutic Competitors 63 non nucleoside inhibitor 63 advanced metastatic renal 63 infectious diseases autoimmune 63 ® chorionic gonadotropin 63 BEMA ® 63 FACTIVE R gemifloxacin 63 ALN HPN 63 vomiting anorexia stomatitis 63 Refractory Hodgkin Lymphoma 63 Ambrisentan 63 unique alkylating agent 63 HCV RNA polymerase 63 Cephalon Oncology 63 Hemispherx flagship products 63 sulfonylhydrazine class 63 StaphVAX R 63 orally administered inhibitor 63 sarcoma melanoma 63 Onalta ™ 63 expanded autologous cellular 63 Oral NKTR 63 pan HDAC inhibitor 63 Atripla combines 63 therapy Tovaxin 63 HER2 Positive 63 BRILINTA 63 Prostate Cancer Vaccine 63 Elotuzumab 63 Durezol TM 63 chemosensitizer 63 cytopenias due 63 oral isoform selective HDAC 63 http:/www.pharmion.com 63 Alseres Cethrin 63 vapreotide acetate 63 Warfarin Coumadin 63 Dose Escalation 63 markets HP Acthar 63 Renal Cell Carcinoma 63 investigational monoclonal antibody 63 Pain Neutralizer holds 63 equine osteoarthritis 63 novel nucleoside analog 63 compound INCB# 63 P#X# antagonist 63 essential thrombocythemia ET 63 proteasome inhibitor 63 dimebon latrepirdine 63 ARRY # 63 Maribavir 63 Interferon beta 1a 63 Ecallantide 63 ABILIFY R 63 ThermoDox ® clinical 63 Vidaza ® 63 Improves Survival 63 5 lipoxygenase inhibitor 63 Shows Promise Against 63 Bucindolol 63 cardiometabolic diseases Glucophage 63 CD# CEA 63 MICRODUR TM 63 oral immunomodulatory 63 AAG KOS 63 PEGylated anti 63 RNAi Therapeutic 63 diets Nevius 63 Syncria R 63 2 methoxyestradiol 63 'S ® DOLMIO 63 rheumatoid arthritis thrombocytopenia 63 METOZOLV TM ODT metoclopramide 63 LibiGel ® 63 vitreoretinal disorders 63 Arno Therapeutics 63 HP Acthar Gel repository 63 approved incretin mimetic 63 Prolongs Survival 63 Prednisporin 63 Piperacillin 63 Oral Calcitonin 63 Oral Suspension USP 63 small molecule vanilloid 63 Nasdaq SMTS develops manufactures 63 Kit CD# positive 63 Complicated Skin 63 Initiates Clinical Trials 63 Merck OSI Pharmaceuticals 63 Fludara ® 63 Hedgehog Pathway Inhibitor 63 drug pipeline TAFA# 63 R chorionic gonadotropin 63 Oral Fingolimod 63 R gemcitabine HCl 63 Albuferon TM 63 Using Dip Pen 63 Transdermal Patch 63 Advancing Drugs 62 Amgen Neulasta ® 62 humanized interleukin 6 62 Announces Poster Presentations 62 candidate AQ4N 62 Solzira ™ 62 delivery polymer matrix 62 Civacir TM Hepatitis C 62 Simulect 62 Phase 2b Trial 62 Testim R 62 ODT metoclopramide HCl PEPCID 62 ALTROPANE R 62 candidate XP# 62 DP VPA 62 Sangamo BioSciences Announces 62 Trofex TM 62 non porcine pancreatic 62 Hormone Refractory Prostate Cancer 62 Panzem R NCD 62 Taisho Pharmaceuticals 62 Inc. NASDAQ IDIX 62 Nasdaq XTLB 62 BARACLUDE R 62 Inc Therapeutic Competitors 62 peptibody 62 Shows Promising 62 Initiates Dosing 62 Omigard TM omiganan pentahydrochloride 62 XP# XP# 62 acetonide FA 62 lintuzumab SGN 62 Initiate Phase 62 ® SHOWTIME WOMEN 62 DELATESTRYL R 62 Darinaparsin Zinapar TM 62 Delta opioid receptor 62 Atridox R Atrisorb 62 NEBIDO VANTAS SUPPRELIN LA 62 Inc. www.coopersurgical.com develops 62 TOCOSOL Camptothecin 62 DG# compounds targeting 62 Intermezzo ® zolpidem tartrate 62 CYCLOSET ® 62 PEG SN# 62 FUSILEV enhances 62 dyslipidemia hypertension diabetes 62 fungal infections malaria tuberculosis 62 IN PATIENTS WITH 62 Dendreon investigational 62 Thrombin topical Recombinant 62 balsalazide disodium Capsules 62 Famvir R 62 liver resection surgeries 62 CCX# B 62 paclitaxel Taxol ® 62 receiving chemoradiation therapy 62 alfimeprase direct 62 Two Upcoming Investor 62 THAT MAKE THE COMPANY 62 developing ostarine selective 62 Pharmacyclics Announces 62 Inc. Nasdaq IMGN 62 IL# PE#QQR 62 Homspera TM 62 Atrisorb D R 62 Nasdaq IMGN 62 BOVESPA PFRM3 62 oral dihydropyrimidine dehydrogenase DPD 62 anti VEGF aptamer 62 ONYX PHARMACEUTICALS 62 www.vivus.com 62 clinical trials Archexin 62 Files Investigational 62 S1P antibody 62 bortezomib Velcade R 62 Chemophase 62 DIURIL R 62 Idera Pharmaceuticals 62 ELND-#/AZD-# 62 influenza BCX# purine nucleoside 62 choriogonadotropin alfa injection 62 Paliperidone Palmitate 62 SUMAVEL 62 proprietary HuCNS SC 62 COPEGUS R 62 arthritis PsA 62 GNSZ 62 Talabostat 62 Pertuzumab 62 small molecule glucokinase 62 ACTEMRA TM 62 Treatment Naïve 62 Factor VIIa Factor VIII 62 Solzira TM 62 Friedreich Ataxia FRDA 62 STELARA TM 62 Namenda Memantine HCl 62 developing Zerenex TM 62 BioGlue R 62 osteolytic bone disease 62 Aztreonam lysine 62 NICE Recommends 62 Bilive R combined 62 Includes KCI proprietary 62 cutaneous T 62 Successfully Completes Phase 62 Adenoscan R 62 alpha folate receptor 62 International LAB Pharma 62 BioDelivery Sciences Announces 62 TM pralatrexate injection 62 cystic fibrosis inflammation autoimmune 62 SATURA ® 62 Hematology Molecular Pathology 62 corticotropin injection 62 inflammatory autoimmune diseases 62 Nexavar prescribing 62 Iluvien ® 62 CD#.# DOES NOT ENDORSE 62 MCSP respectively 62 Symbioscience WISDOM PANEL 62 GW# [003] 62 combines bupropion 62 OMRIX Biopharmaceuticals 62 Alzheimer disease cognitive dysfunction 62 Advanced Renal Cell 62 Genentech sanofi aventis 62 anti botulism antibody 62 AMITIZA R 62 Cyclooxygenase Inhibiting Nitric Oxide 62 JAK2 Inhibitor 62 R bisoprolol Euthyrox 62 Kuvan R 62 GTC recombinant human 62 R roscovitine CDK cyclin 62 OTCBB QTXB 62 R memantine HCl 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 Gemcitabine HCI 62 Known hypersensitivity 62 3 registrational trial 62 IMPACS TM 62 memantine HCl 62 hypoxia selective 62 pseudobulbar affect PBA 62 Panzem NCD 62 Dyax logo 62 small molecule thrombopoietin 62 Aradigm Logo 62 Cephalon GlaxoSmithKline 62 Novel Oral 62 Pivotal Trial 62 OAB overactive bladder 62 Presents Preclinical 62 certain protein tyrosine 62 REPRONEX R menotropins 62 Zenvia ™ 62 kidney urologic 62 ALVESCO ® 62 Epratuzumab 62 successfully commercialize Iluvien 62 Medidur ™ FA 62 HGS ETR1 mapatumumab 62 cetuximab Erbitux R 62 somatropin Kuvan R 62 neuropathic pain spasticity 62 Tumour Vascular Disrupting Agent 62 Etelos Cloud 62 novel proprietary KL4 62 Generic Version Of 62 metastatic ocular 62 Synta Announces 62 Phase III Pivotal 62 Gemzar ® 62 TRISENOX R arsenic trioxide 62 epilepsy neuropathic pain 62 Entereg R 62 transthyretin mediated amyloidosis ATTR 62 PINNACLEDIGEST.COM S PAST PERFORMANCE 62 By JAMAAL ABDUL 62 targets HGF FGFR 62 Cytogen marketed 62 Allovectin 7 r 62 gastrointestinal mucositis 62 ® bevacizumab 62 Advanced Melanoma 62 Cleviprex TM clevidipine 62 Ridaforolimus 62 non personalized allogeneic 62 MEDA AB publ 62 Onalta 62 ABRAXANE TM 62 Spectrum Pharmaceutical 62 Diabetic Macular Edema 62 Cannabinor 62 relapsed multiple myeloma 62 Dementia Related Psychosis 62 targeted antifolate 62 BENLYSTA TM 62 specifically hypoactive sexual 62 BYETTA ® 62 Inc. NASDAQ AEZS 62 MT#/MEDI-# 62 Novolimus 62 THR beta agonist 62 Colaris Colaris AP 62 Dexilant 62 Ixempra 62 ospemifene 62 ® natalizumab 62 SUPPRELIN R LA 62 SUTENT ® 62 oral nucleoside analogue 62 reformulates existing FDA 62 OTC BB PVCT http:/www.pvct.com 61 lexidronam injection 61 Palonosetron 61 oropharyngeal candidiasis OPC 61 Other Joint Prosthesis 61 Antibody Drug Conjugate 61 docetaxel Taxotere R 61 platinum chemotherapeutic 61 estrogen receptor beta agonist 61 Pivotal Phase 61 Silodosin 61 Anthracycline 61 PLK1 SNALP 61 LEVADEX orally inhaled 61 psoriasis rheumatoid arthritis 61 Nicotine Conjugate Vaccine 61 Sumatriptan Succinate 61 phase III isavuconazole 61 novel oral anticoagulant 61 oral ghrelin agonist 61 developing Zerenex ferric 61 targeted anticancer biopharmaceuticals 61 XOMA 3AB biodefense 61 mertansine 61 tiapamil 61 R rilonacept Injection 61 Transcept Pharmaceuticals 61 interferon alpha IFN 61 signal detection CTSD 61 Fortical ® Unigene nasal 61 Lupus Nephritis 61 interferon gamma 1b 61 Launches Generic Version 61 Epothilone D 61 liposomal formulation 61 Humanized Anti 61 selectin antagonist 61 Biogen Genentech 61 ASE SVA 61 ENL recurrence 61 multi kinase inhibitor 61 Randomized Phase II 61 RhuDex ® 61 POSIDUR TM ELADUR TM 61 Mg Usa 61 Peginterferon alfa 2a 61 enhanced skin permeation 61 benzoic acid hyoscyamine sulfate 61 Pruvel ™ prulifloxacin 61 PROCTOCORT R Suppository Hydrocortisone 61 Ketotransdel 61 developing Surfactant Replacement 61 Cyclacel Pharmaceuticals 61 Corp. www.anavex.com 61 phenylketonuria PKU developed 61 SHRED MATRIX ® 61 NMT Medical Announces 61 Trastuzumab DM1 61 Myrexis Inc. 61 nilotinib Tasigna ® 61 selective angiogenic kinase inhibitor 61 Boxed WARNINGS 61 failure thrombosis embolism 61 IMPACS R 61 antibody MAb 61 Daclizumab 61 sNDAs 61 PrevOnco 61 Single Dose 61 CAMPATH 61 CRM# Protein 61 TAXUS Element Paclitaxel Eluting 61 vancomycin hydrochloride 61 proprietary polysaccharide 61 cough nasopharyngeal pain 61 calcium acetate Nabi HB 61 Vytorin combines 61 trial evaluating PRX# 61 docetaxel Taxotere ® 61 Inc. Nasdaq OXGN 61 IND Filing 61 GVT BMF & 61 CD4 monoclonal antibody 61 therapeutically inactive prodrug 61 product Abreva R 61 selective inverse agonist 61 decreased matrix metalloproteinase 61 Golimumab 61 ® PLEDGE 61 Marqibo TM 61 valtorcitabine 61 IV meropenem 61 Oracea R 61 AzaSite Xtra 61 includes TOLAMBA TM 61 cell carcinoma RCC 61 Diabetic Macular Edema DME 61 Intravenous CP 61 LymphoStat B TM 61 TRAIL receptor antibodies 61 Liprotamase 61 Pivotal Study 61 Initiates Phase 2b 61 proprietary BiTE ® 61 palifosfamide Zymafos TM 61 generation proteasome inhibitor 61 Copegus ® 61 gastrointestinal stromal 61 Bayer Onyx 61 Lenocta TM 61 Paraplatin ® 61 Oral Solution VISICOL 61 Ticagrelor 61 Demonstrates Sustained 61 relapsed leukemia 61 HDAC Inhibitor 61 LEVADEX ™ 61 NYSE Amex YMI 61 TRISENOX R 61 novel MetAP 2 61 Fortical R 61 Trubion proprietary 61 Vasomedical enhanced 61 Akesis Pharmaceuticals 61 candidate MyVax 61 intranasal vaccines derived 61 STOP COMPLAINING AND 61 PI3K/Akt pathway inhibitor 61 CG# oncolytic virus 61 folinic acid FA 61 HAS WRITTEN 61 oral Janus kinase 61 Micromet proprietary BiTE 61 Reveals Positive 61 please visit http:/www.avastin.com 61 Polyphenon ® E 61 Shows Efficacy 61 tranquilizers diazepam 61 Oxytrol R 61 mark eOn 61 prescribed proton pump 61 DO YOU NEED TO 61 proprietary intravenous formulation 61 BiTE R 61 polyglutamate 61 Present Preclinical Data 61 fatigue headache chills 61 Carfilzomib 61 Racivir 61 includes Dideco CarboMedics 61 catheter occlusion 61 generation purine nucleoside 61 toenail onychomycosis 61 www.BYETTA.com 61 investigational immunotherapy 61 Release Tablets 61 sunitinib Sutent ® 61 metabolic disorders Saizen R 61 About Positron Positron 61 #-# rDNA origin 61 plus prednisone prednisolone 61 Submits Response 61 Soriatane 61 Relapsed Multiple Myeloma 61 Recombinant Human 61 OPTION 'S 61 AVEO Pharmaceuticals NASDAQ 61 CRMD# 61 Teikoku Pharma USA 61 XAGRID 61 TFChem licenses 61 Relapsed Refractory 61 RESTORE CLI trial 61 radiation sensitizer 61 rotavirus shingles 61 treat chronic sinusitis 61 www.ucb.com 61 IV Busulfex 61 Squalamine 61 XOPENEX R 61 Emergent marketed 61 hematological cancers notably 61 IV APAP 61 Pirespa 61 Transgenomic Pharmacogenomics Services 61 Hematological Malignancies 61 AcryMed Incorporated